|
13 Apr 2026 |
Sagility
|
Consensus Share Price Target
|
42.11 |
57.40 |
- |
36.31 |
buy
|
|
|
|
|
27 Mar 2026
|
Sagility
|
ICICI Securities Limited
|
42.11
|
66.00
|
39.89
(5.57%)
|
56.73 |
Buy
|
|
|
Sagility hosted its first analyst meet (on 25th Mar’26). It highlighted that AI continues to be a key growth driver, woven into most of its solutions and platforms.
|
|
27 Mar 2026
|
Sagility
|
Prabhudas Lilladhar
|
42.11
|
|
41.75
(0.86%)
|
|
Not Rated
|
|
|
Create domain specific agentic AI solutions to expand TAM Sustain revenue momentum while maintaining margins We attended Sagility's Investor Day, where management outlined how US healthcare policy changes and AI adoption are reshaping its business, and how the company is turning these headwinds into growth opportunities. Policy-driven margin pressures on payer clients are accelerating the shift toward cost-saving outsourcing, where Sagility's human in the loop agentic solutions, built on two decades of domain expertise across both payers and providers, can reduce client costs and effort by ~30%...
|
|
27 Mar 2026
|
Sagility
|
Geojit BNP Paribas
|
42.11
|
50.00
|
41.75
(0.86%)
|
18.74 |
Buy
|
|
|
Sagility Ltd. is a healthcare-focused, technology-enabled solutions provider primarily serving U.S. health insurers (payers), along with hospitals, physicians, and medical device companies (providers). Headquartered in Bengaluru, the company operates 33 delivery centers across India, the U.S., and other global markets. In Q3FY26, ~90% of its revenue...
|
|
26 Mar 2026
|
Sagility
|
Motilal Oswal
|
42.11
|
58.00
|
39.89
(5.57%)
|
37.73 |
Buy
|
|
|
Growth strategies are clearly anchored around: cost transformation driven by demand from US payers; capability-led differentiation, including AI.
|
|
28 Jan 2026
|
Sagility
|
Motilal Oswal
|
42.11
|
66.00
|
51.70
(-18.55%)
|
56.73 |
Buy
|
|
|
Sagility’s 3QFY26 revenue rose 29.1% YoY in Constant Currency (CC), higher than our estimate of 21% YoY CC. EBIT margin stood at 19.7%, and adj. PAT came in at INR3.2b (up 7.3% QoQ and 23.0% YoY), well above our estimate of INR2.8b.
|
|
10 Sep 2025
|
Sagility
|
Geojit BNP Paribas
|
42.11
|
55.00
|
44.27
(-4.88%)
|
Target met |
Buy
|
|
|
Sagility India Ltd. is a healthcare-focused, technology-enabled solutions provider, serving primarily U.S. health insurers (Payers) and, to a lesser extent, hospitals, physicians, and medical device companies (Providers). Headquartered in Bengaluru, it operates 33 centres across India, the U.S., and other global markets. In Q1FY26, 88.4% of revenue was derived...
|
|
16 May 2025
|
Sagility
|
ICICI Securities Limited
|
42.11
|
60.00
|
46.78
(-9.98%)
|
42.48 |
Buy
|
|
|
Sagility India reported 5.8% QoQ USD revenue growth (organic growth at 0.7%), slightly ahead of I-Sec estimate in Q4FY25. It met its guidance of delivering mid-teens growth in FY25 with 15% YoY USD print.
|
|
05 Nov 2024
|
Sagility
|
HDFC Securities
|
42.11
|
|
|
|
IPO Note
|
|
|
IPO Note - Sagility India Limited Issue Snapshot: Issue Open: November 05 November 07, 2024 Price Band: Rs. 28 30 (Employee discount of Rs 2 per share) *Issue Size: Up to Rs 2106.60 cr (Offer for sale of 70.21 crore shares) Reservation for: QIB atleast 75% eq sh Non-Institutional upto 15% eq sh ((including 1/3rd for applications between Rs.2 lakhs to Rs.10 lakhs)) Retail upto 10% eq sh Face Value: Rs 10 Book value: Rs 16.25 (June 30, 2024) Bid size: - 500 equity shares and in multiples thereof 100% Book built Issue
|
|
04 Nov 2024
|
Sagility
|
Ventura
|
42.11
|
|
|
|
IPO Subscribe
|
|
|
|
|
04 Nov 2024
|
Sagility
|
SBI Securities
|
42.11
|
|
|
|
IPO Avoid
|
|
|
|